{
  "entities": {
    "activities": {
      "35e299d8-300e-4cdf-944c-a4998bf3774e": "12-Lead Electrocardiogram",
      "32e621de-8913-4f06-9db9-e2b010553d46": "12-lead ECG",
      "0f979d22-1a11-4ab4-9b93-0e29b48d8a18": "ACTH",
      "f8e55774-b0c7-4450-aafd-760bccbe9f90": "Adverse Events",
      "e3176130-955e-4bfd-87bd-a229cb35f17f": "Anti-Avelumab Antibodies and Neutralizing Antibodies",
      "f77d4a51-69ee-4ee1-9f63-842cdc29aba4": "Avelumab (Arm A only)",
      "180f3a18-d3c5-450d-8a84-d0c201b998b5": "Axitinib (Arm A only)",
      "8f80fb62-f28d-4bb3-90eb-34256a31f880": "Axitinib/Sunitinib Dosing Compliance Follow-up",
      "24b65273-9995-4b48-a681-b08fc4cc7576": "Banked Blood Biospecimens",
      "88268aef-6cbf-4346-bb11-761ff146603c": "Baseline Signs/Symptoms",
      "b734af07-200d-45ad-9884-14ed99282d42": "Blood Chemistry- Core Panel",
      "9dcae8e9-9f07-403d-bbe5-40181cdedf33": "Blood Chemistry-Full panel",
      "db6f3c10-79b4-45f0-8f45-bc53bb3347e2": "Blood Pressure Home Monitoring",
      "37670afe-759f-4e09-8903-d4ee4f8ead3c": "Blood Sample Collection",
      "facfd4ef-7670-433b-ba28-df2b197617d8": "Bone Scintigraphy",
      "9ecec756-fa83-4fe0-b88b-399bdca9e3ec": "Cardiac Enzymes",
      "9046861a-b0ff-4bfe-b3da-b4f06b413c01": "Coagulation",
      "12592ab9-63c9-4e40-a411-7034d330a3e8": "Computed Tomography",
      "ebe0768a-a5e9-4991-8dca-5ae3e4eb7d2c": "Concomitant Medications/Treatments",
      "bd480bc1-306a-4651-87dd-56a4a399f89b": "Contraception Check",
      "9a236f5a-fdc4-4933-9908-294d8624acec": "ECOG Performance Status",
      "943877f7-1030-4d3e-9b88-421e25e173c6": "Echocardiogram",
      "1d396684-cab8-4369-9960-24c43e19b101": "FKSI and EuroQol 5-Dimension (EQ-5D)",
      "f5c39de7-471f-4862-9b20-fa6672548ee2": "HBV, HCV Tests",
      "59d9cd16-02a3-48b2-99ba-8bf9378e8a55": "Hematology",
      "0b7b95b7-11b5-43aa-b463-0efa7cf3972e": "Informed Consent",
      "9740a860-cafb-4b53-8db0-d8dd5faa7b63": "Intravenous Infusion",
      "f31736d2-9be4-461f-b498-dc86edb134b8": "MUGA Scan or ECHO",
      "69796984-7832-4dbe-a2e8-33ec7e943bd2": "Magnetic Resonance Imaging",
      "4a34dd0e-0f5e-4057-9ff7-f53c996639ee": "Mandatory Archival FFPE Tumor Tissue",
      "5f0e9d63-9c72-413d-b9ce-16d2254728d8": "Mandatory Recent FFPE Tumor Tissue Block",
      "1e3c7692-ca2d-4eec-bbb4-2000164b4071": "Medical/Oncological History",
      "2542dd1c-21d4-42dd-bb04-36169caeed15": "Pharmacokinetics for avelumab",
      "4bb8427d-2f26-4f96-8d4d-7a355e3002dd": "Pharmacokinetics for axitinib",
      "9851f7f0-a98d-4762-9623-cbb3506648f1": "Physical Examination",
      "1d16df51-8598-4ba7-bfc1-9a0ba08403d9": "Serum/Urine Pregnancy Test",
      "8dbe3ec3-69e4-4790-8cd1-e3298d40516f": "Sunitinib (Arm B only)",
      "cefad2bc-2aaa-49d5-9992-a16d85c7d57d": "Thyroid Function Tests",
      "c3baa0d8-89a1-4c26-a5c7-9a6e062affdf": "Tumor Assessments (including scans)",
      "d0d1c833-c98e-4855-b432-fe02823180c5": "Tumor Biopsy",
      "8c88e39c-b8e1-4548-a8d9-95cd40714d0e": "Urinalysis",
      "79410bc0-f067-4f04-aba6-6febeb69a970": "Vital Signs",
      "34de608a-8b2a-4832-8f5a-32538b67a4ac": "Vital Signs Monitoring"
    },
    "plannedTimepoints": {},
    "encounters": {
      "0a54ff3a-a705-4353-951a-5f270476f5d6": "Cycle 1 Day 1",
      "d758a430-12b8-45b4-aae6-8af5db4f96fc": "Cycles \u22652 Day 1 (\u00b13 days)",
      "56696c34-a270-4c31-8746-f4a8fd851a50": "Cycle 1 Day 15 (\u00b13 days)",
      "89beac77-9d47-4487-abe1-6c450148c619": "Cycles \u22652 Day 15 (\u00b13 days)",
      "a8b87733-91e2-41f5-8602-ef07e3c2dcc2": "Cycle 1 Day 29 (\u00b13 days)",
      "91060bd1-1841-46f3-b7e7-fb20c1c35a72": "Cycles \u22652 Day 29 (\u00b13 days)",
      "0d4b6607-be1a-45fb-bc8a-bcc8ee359179": "Screening (\u226428 Days Prior to Randomization)"
    },
    "epochs": {
      "beaf2674-dde9-4a30-80e0-42bf60f15b84": "Screening",
      "d56e9322-dea4-445b-94de-6979790a52d5": "Study Treatment"
    },
    "activityGroups": {}
  },
  "cells": {
    "4a34dd0e-0f5e-4057-9ff7-f53c996639ee|0d4b6607-be1a-45fb-bc8a-bcc8ee359179": "both",
    "5f0e9d63-9c72-413d-b9ce-16d2254728d8|0d4b6607-be1a-45fb-bc8a-bcc8ee359179": "both",
    "e3176130-955e-4bfd-87bd-a229cb35f17f|0a54ff3a-a705-4353-951a-5f270476f5d6": "both",
    "e3176130-955e-4bfd-87bd-a229cb35f17f|56696c34-a270-4c31-8746-f4a8fd851a50": "both",
    "e3176130-955e-4bfd-87bd-a229cb35f17f|a8b87733-91e2-41f5-8602-ef07e3c2dcc2": "both",
    "e3176130-955e-4bfd-87bd-a229cb35f17f|d758a430-12b8-45b4-aae6-8af5db4f96fc": "both",
    "e3176130-955e-4bfd-87bd-a229cb35f17f|91060bd1-1841-46f3-b7e7-fb20c1c35a72": "both"
  },
  "cellFootnotes": {
    "4a34dd0e-0f5e-4057-9ff7-f53c996639ee|0d4b6607-be1a-45fb-bc8a-bcc8ee359179": [
      "26"
    ],
    "5f0e9d63-9c72-413d-b9ce-16d2254728d8|0d4b6607-be1a-45fb-bc8a-bcc8ee359179": [
      "27"
    ],
    "e3176130-955e-4bfd-87bd-a229cb35f17f|0a54ff3a-a705-4353-951a-5f270476f5d6": [
      "28"
    ],
    "e3176130-955e-4bfd-87bd-a229cb35f17f|56696c34-a270-4c31-8746-f4a8fd851a50": [
      "28"
    ],
    "e3176130-955e-4bfd-87bd-a229cb35f17f|a8b87733-91e2-41f5-8602-ef07e3c2dcc2": [
      "28"
    ],
    "e3176130-955e-4bfd-87bd-a229cb35f17f|d758a430-12b8-45b4-aae6-8af5db4f96fc": [
      "28"
    ],
    "e3176130-955e-4bfd-87bd-a229cb35f17f|91060bd1-1841-46f3-b7e7-fb20c1c35a72": [
      "28"
    ]
  },
  "metadata": {
    "model": "gemini-3-flash-preview",
    "extraction_type": "text"
  }
}